Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1072 GI-108, a novel bispecific fusion protein augments anti-tumor immunity by alleviating immunosuppressive adenosine pathway in CD8+ T cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
